keyword
Keywords Asthma biological therapies an...

Asthma biological therapies and cancer

https://read.qxmd.com/read/37149747/chemical-inhibition-of-dna-pkcs-impairs-the-activation-and-cytotoxicity-of-cd4-helper-and-cd8-effector-t-cells
#21
JOURNAL ARTICLE
Ana C Azevedo-Pouly, Lauren E Appell, Lyle Burdine, Lora J Rogers, Lauren C Morehead, Daniel Fil, Melanie Barker, Randall R Rainwater, Zachary J Waldrip, Brian Koss, Marie Schluterman Burdine
Modulation of T cell activity is an effective strategy for the treatment of autoimmune diseases, immune-related disorders and cancer. This highlights a critical need for the identification of proteins that regulate T cell function. The kinase DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is emerging as a potent regulator of the immune system, spurring interest in its use as a therapeutic target. In murine models of immune-related diseases including asthma and rheumatoid arthritis, treatment with small-molecule DNA-PKcs inhibitors decreased the disease severity...
May 6, 2023: Immunology and Cell Biology
https://read.qxmd.com/read/37100206/aerosol-pulmonary-immune-engineering
#22
REVIEW
Emma R Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, Kartik Bomb, Catherine A Fromen
Aerosolization of immunotherapies poses incredible potential for manipulating the local mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders, and accessing mucosal associated lymphoid tissue to redirect systemic adaptive and memory responses. In this review, we breakdown key inhalable immunoengineering strategies for chronic, genetic, and infection-based inflammatory pulmonary disorders, encompassing the historic use of immunomodulatory agents, the transition to biological inspired or derived treatments, and novel approaches of complexing these materials into drug delivery vehicles for enhanced release outcomes...
April 24, 2023: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/36931148/il-36-expression-is-increased-in-nsclc-with-il-36-stimulation-of-lung-cancer-cells-promoting-a-pro-tumorigenic-phenotype
#23
JOURNAL ARTICLE
Kevin James Baker, Emily Buskiewicz, Méabh Finucane, Adeleine Chelliah, Louise Burke, Aileen Houston, Elizabeth Brint
The IL-36 cytokines are a recently described subset of the IL-1 family of cytokines, and have been shown to play a role in the pathogenesis of respiratory diseases such as asthma and COPD. Given the common aetiological links between COPD and lung cancer development, as well as the involvement of other IL-1 family members in lung tumorigenesis, the aim of this work was to investigate the role of IL-36 cytokines in the pathogenesis of lung cancer. In this study we demonstrate that expression of IL-36 cytokines and receptor mRNA and protein are significantly increased in lung cancer tissue compared to adjacent non-tumour tissue...
March 15, 2023: Cytokine
https://read.qxmd.com/read/36915991/the-value-of-emerging-prostate-cancer-associated-lncrna-pcgem1-in-various-tumors
#24
JOURNAL ARTICLE
Xing Lv, Mingzhu Zhang, Wen Xu
BACKGROUND: LncRNA not only plays an auxiliary role as an intermediate carrier of genetic information, but also mediates various regulatory functions. The complex and precise regulatory function of lncRNA in development and gene expression has greatly explained the complexity of the genome, and also opened a new avenue for people to understand the complexity of life from the dimension of gene expression. Long non-coding RNA (lncRNA) prostate cancer gene expression marker 1 (PCGEM1) is a characterized oncogenic lncRNA in different cancers...
March 13, 2023: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/36906975/the-emerging-diagnostic-and-therapeutic-roles-of-small-nucleolar-rnas-in-lung-diseases
#25
REVIEW
Xiaoying Liu, Md Khadem Ali, Lan Zhao, Kamal Dua, Yuqiang Mao
Small nucleolar RNAs (snoRNAs) are non-coding RNA molecules that range from 60 to 300 nucleotides in length and are primarily located in the nucleoli of cells. They play a critical role in modifying ribosomal RNA and can also regulate alternative splicing and posttranscriptional modification of mRNA. Alterations in snoRNA expression can affect numerous cellular processes, including cell proliferation, apoptosis, angiogenesis, fibrosis, and inflammation, making them a promising target for diagnostics and treatment of various human pathologies...
March 10, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36903645/bruton-s-tyrosine-kinase-inhibitors-btkis-review-of-preclinical-studies-and-evaluation-of-clinical-trials
#26
REVIEW
Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
In the last few decades, there has been a growing interest in Bruton's tyrosine kinase (BTK) and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) signaling pathway and affects B-cell proliferation and differentiation. Evidence demonstrating the expression of BTK on the majority of hematological cells has led to the hypothesis that BTK inhibitors (BTKIs) such as ibrutinib can be an effective treatment for leukemias and lymphomas. However, a growing body of experimental and clinical data has demonstrated the significance of BTK, not just in B-cell malignancies, but also in solid tumors, such as breast, ovarian, colorectal, and prostate cancers...
March 6, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36883260/the-role-of-bone-morphogenetic-protein-4-in-lung-diseases
#27
JOURNAL ARTICLE
Xiaoxiao Dong, Yimin Mao, Pengfei Gao
Bone morphogenetic protein 4 (BMP4) is a multifunctional secretory protein that belongs to the transforming growth factor β superfamily. BMPs transduce their signaling to the cytoplasm by binding to membrane receptors of the serine/threonine kinase family, including BMP type I and type II receptors. BMP4 participates in various biological processes, such as embryonic development, epithelial-mesenchymal transition, and maintenance of tissue homeostasis. The interaction between BMP4 and the corresponding endogenous antagonists plays a key role in the precise regulation of BMP4 signaling...
2023: Current Molecular Medicine
https://read.qxmd.com/read/36835169/bio-guided-isolation-of-compounds-from-fraxinus-excelsior-leaves-with-anti-inflammatory-activity
#28
JOURNAL ARTICLE
Małgorzata Kołtun-Jasion, Paulina Sawulska, Andrzej Patyra, Marta Woźniak, Marta Katarzyna Dudek, Agnieszka Filipek, Anna Karolina Kiss
Inflammation is the first physiological defence mechanism against external and internal stimuli. The prolonged or inappropriate response of the immune system may lead to the persistent inflammatory response that can potentially become a basis for chronic diseases e.g., asthma, type II diabetes or cancer. An important role in the alleviation of inflammatory processes, as an adjunct to traditional pharmacological therapy, is attributed to phytotherapy, especially to raw materials with a long tradition of use, e...
February 13, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36822022/emerging-role-of-macrophages-in-non-infectious-diseases-an-update
#29
REVIEW
Hassan Yousaf, Malik Ihsan Ullah Khan, Iftikhar Ali, Muhammad Usman Munir, Ka Yiu Lee
In the past three decades, a huge body of evidence through various research studies conducted on animal models, has demonstrated that the macrophages are centralized of all the leukocytes involved in diseases and, particularly, their role in non-infectious diseases has been studied extensively for which they have also been referred to as the "double-edged swords". The most versatile of all immunocytes, macrophages play a key role in health and diseases. Various experimental models have demonstrated the conventional paradigms such as the M1/M2 dichotomy, which is not as obvious and presents a complex characterization of the macrophages in the disease immunology...
February 21, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36802038/synergistic-activity-of-colistin-in-combination-with-clofoctol-against-colistin-resistant-gram-negative-pathogens
#30
JOURNAL ARTICLE
Diletta Collalto, Alessandra Fortuna, Paolo Visca, Francesco Imperi, Giordano Rampioni, Livia Leoni
Colistin is a bactericidal antibiotic identified decades ago which is active against a number of Gram-negative pathogens. After early elimination from clinical use due to toxicity issues, colistin has been reintroduced as a last-resort treatment for antibiotic-resistant Gram-negative infections lacking other therapeutic options. Inevitably, colistin resistance has emerged among clinical isolates, making the development of colistin adjuvants extremely beneficial. Clofoctol is a synthetic antibiotic active against Gram-positive bacteria, with low toxicity and high tropism for the airways...
February 21, 2023: Microbiology Spectrum
https://read.qxmd.com/read/36768438/dihomo-%C3%AE-linolenic-acid-20-3n-6-metabolism-derivatives-and-potential-significance-in-chronic-inflammation
#31
REVIEW
Anne-Mari Mustonen, Petteri Nieminen
Dihomo- γ -linolenic acid (DGLA) has emerged as a significant molecule differentiating healthy and inflamed tissues. Its position at a pivotal point of metabolic pathways leading to anti-inflammatory derivatives or via arachidonic acid (ARA) to pro-inflammatory lipid mediators makes this n-6 polyunsaturated fatty acid (PUFA) an intriguing research subject. The balance of ARA to DGLA is probably a critical factor affecting inflammatory processes in the body. The aim of this narrative review was to examine the potential roles of DGLA and related n-6 PUFAs in inflammatory conditions, such as obesity-associated disorders, rheumatoid arthritis, atopic dermatitis, asthma, cancers, and diseases of the gastrointestinal tract...
January 20, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36695072/expert-consensus-on-the-systemic-treatment-of-atopic-dermatitis-in%C3%A2-special-populations
#32
REVIEW
D N Adam, M J Gooderham, J R Beecker, C H Hong, C S Jack, V Jain, P Lansang, C W Lynde, K A Papp, V H Prajapati, I Turchin, J Yeung
With the increasing number of options for the treatment of moderate-to-severe atopic dermatitis, clinicians need guidance on a practical approach to selecting a systemic agent for specific patient populations. We convened an expert panel consisting of 12 members to conduct a literature review and summarize relevant data related to six scenarios of clinical interest: comorbid asthma, ocular surface disease, history of cancer, past and ongoing infections of interest (including herpes simplex virus, herpes zoster, hepatitis B, and tuberculosis), pregnancy and lactation, and the elderly...
January 25, 2023: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/36555280/cc-chemokine-receptor-4-ccr4-as-a-possible-new-target-for-therapy
#33
REVIEW
Joanna Bogacka, Katarzyna Pawlik, Katarzyna Ciapała, Agata Ciechanowska, Joanna Mika
Chemokines and their receptors participate in many biological processes, including the modulation of neuroimmune interactions. Approximately fifty chemokines are distinguished in humans, which are classified into four subfamilies based on the N-terminal conserved cysteine motifs: CXC, CC, C, and CX3C. Chemokines activate specific receptors localized on the surface of various immune and nervous cells. Approximately twenty chemokine receptors have been identified, and each of these receptors is a seven-transmembrane G-protein coupled receptor...
December 9, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36503460/montelukast-inhibits-lung-cancer-cell-migration-by-suppressing-cysteinyl-leukotriene-receptor-1-expression-in-vitro
#34
JOURNAL ARTICLE
Yisheng Chen, Jinye Zhang, Shuo Wei
BACKGROUND: Lung cancer is a major threat to public health and remains difficult to treat. Repositioning of existing drugs has emerged as a therapeutic strategy in lung cancer. Clinically, low-dose montelukast has been used to treat asthma. OBJECTIVE: We evaluated the potential of using montelukast to treat lung cancer. METHODS: Migration was detected using wound-healing and Transwell assays, the expression of CysLT1 using western blotting, and subcellular localization of CysLT1 using immunofluorescence...
2023: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/36502752/recent-advances-in-ginsenosides-against-respiratory-diseases-therapeutic-targets-and-potential-mechanisms
#35
REVIEW
Lu Ding, Hongyu Qi, Yisa Wang, Zepeng Zhang, Qing Liu, Chen Guo, Jiaqi Liu, Zhaoqiang Chen, Jing Li, JinJin Chen, Qingxia Huang, Daqing Zhao, Zeyu Wang, Xiangyan Li
BACKGROUND: Respiratory diseases mainly include asthma, influenza, pneumonia, chronic obstructive pulmonary disease, pulmonary hypertension, lung fibrosis, and lung cancer. Given their high prevalence and poor prognosis, the prevention and treatment of respiratory diseases are increasingly essential. In particular, the development for the novel strategies of drug treatment has been a hot topic in the research field. Ginsenosides are the major component of Panax ginseng C. A. Meyer (ginseng), a food homology and well-known medicinal herb...
December 8, 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36445652/utilizing-biologics-in-drug-desensitization
#36
REVIEW
Barbara C Yang, Mariana C Castells
PURPOSE OF REVIEW: The purpose of this literature review was to review the latest advancements with biologics in rapid drug desensitization. Our methodology was to highlight both desensitization to biologics themselves and the use of biologics in desensitization to both biologic and nonbiologic drugs. RECENT FINDINGS: Biologics are a vast category of drugs that include monoclonal antibodies, nanobodies, modern vaccinations, and even hormones. Desensitization to biologics can be safely performed through standardized procedure...
November 29, 2022: Current Allergy and Asthma Reports
https://read.qxmd.com/read/36411631/anti-inflammatory-and-anti-allergic-potential-of-dietary-flavonoids-a-review
#37
REVIEW
Allah Rakha, Nehal Umar, Roshina Rabail, Masood Sadiq Butt, Marek Kieliszek, Abdo Hassoun, Rana Muhammad Aadil
Chronic inflammation plays an imperative role in the onset and progression of chronic diseases including diabetes, hypertension, cancer, allergies, and asthma. Diet can modulate different stages of inflammation since it is a rich source of antioxidants and bioactive compounds. Flavonoids are bioactive compounds abundantly found in various food groups such as vegetables, fruits, nuts, cereals, and beverages. Recent work on flavonoids has unveiled their potential to regulate or inhibit inflammation. This is attributed to their anti-inflammatory, anti-oxidative, and immune-modulatory properties, making flavonoids an invaluable component in nutraceutical, pharmaceutical, and medicinal applications...
December 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36271564/recent-advances-in-respiratory-diseases-dietary-carotenoids-as-choice-of-therapeutics
#38
REVIEW
Fahadul Islam, Maniza Muni, Saikat Mitra, Talha Bin Emran, Deepak Chandran, Rajib Das, Abdur Rauf, Sher Zaman Safi, Kumarappan Chidambaram, Manish Dhawan, Chunhoo Cheon, Bonglee Kim
A group of bioactive, isoprenoid pigments known as carotenoids is mostly present in fruits and vegetables. Carotenoids are essential for the prevention of physiological issues, which makes maintaining excellent health easier. They are effective functional ingredients with potent health-promoting properties that are widely present in our food and linked to a decrease in the prevalence of chronic diseases, including respiratory diseases. Respiratory infections are the primary cause of death and life-threatening conditions globally, wreaking havoc on the global health system...
November 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36180072/oxmif-a-druggable-isoform-of-macrophage-migration-inhibitory-factor-in-cancer-and-inflammatory-diseases
#39
REVIEW
Michael Thiele, Seamas C Donnelly, Robert A Mitchell
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine with a pleiotropic spectrum of biological functions implicated in the pathogenesis of cancer and inflammatory diseases. MIF is constitutively present in several cell types and non-lymphoid tissues and is secreted after acute stress or inflammation. MIF triggers the release of proinflammatory cytokines, overrides the anti-inflammatory effects of glucocorticoids, and exerts chemokine function, resulting in increased migration and recruitment of leukocytes into inflamed tissue...
September 2022: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/36076514/ferroptosis-novel-therapeutics-in-asthma
#40
REVIEW
Xiaodi Lv, Ming Dong, Weifeng Tang, Jingjing Qin, Wenqian Wang, Mihui Li, Fangzhou Teng, La Yi, Jingcheng Dong, Ying Wei
Ferroptosis, an iron-dependent form of regulated cell death, was recently demonstrated to be closely associated with the immune system. Regulators of ferroptosis may be the cells and secretions of the immune system. Ferroptosis has contributed to the progression of various diseases, namely, cancer, ischemia, and degenerative diseases. However, research on the relationship between ferroptosis and asthma remains fragmented. Non-immune cells associated with asthma are also closely associated with ferroptosis. Further studies on cross-linking asthma inflammation with ferroptosis signaling pathways could help identify several key molecules, known as ferroptosis regulators, that regulate asthma...
September 2022: Biomedicine & Pharmacotherapy
keyword
keyword
71013
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.